Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 54 Lung Neoplasms 42 Adenocarcinoma of Lung 8 Neoplasm Metastasis 6 Adenocarcinoma, Bronchiolo-Alveolar 4 Melanoma 3 Carcinoma, Renal Cell 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Mesothelioma, Malignant 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Carcinoma 2 Breast Neoplasms 2 Unresectable Stage III NSCLC 1 Thymus Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Pain 1 Ovarian Neoplasms 1 Mesothelioma 1 Lung Cancer Metastatic 1 Liposarcoma, Myxoid 1

Interventions

Pemetrexed 40 Cisplatin 35 pembrolizumab 21 Nivolumab 17 Carboplatin 16 Ipilimumab 13 Gemcitabine 10 Cyclophosphamide 9 fludarabine 6 durvalumab 6 Bevacizumab 6 Radiotherapy, Intensity-Modulated 4 LMB-100 4 Drug Therapy 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 spartalizumab 3 olaparib 3 niraparib 3 atezolizumab 3 anetumab ravtansine 3 amatuximab 3 Vinorelbine 3 Paclitaxel 3 Oxaliplatin 3 Imatinib Mesylate 3 Fluorouracil 3 Cerebral Decortication 3 Blood Specimen Collection 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma × Radiation × Thoracic × Clear all

NCT01604005 2018-01-29

PIT

The Christie NHS Foundation Trust

Phase 3 Terminated

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡